Package 16714-070-02

Brand: fulvestrant

Generic: fulvestrant
NDC Package

Package Facts

Identity

Package NDC 16714-070-02
Digits Only 1671407002
Product NDC 16714-070
Description

2 SYRINGE, GLASS in 1 CARTON (16714-070-02) / 5 mL in 1 SYRINGE, GLASS (16714-070-01)

Marketing

Marketing Status
Marketed Since 2021-08-23
Brand fulvestrant
Generic fulvestrant
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR"], "spl_id": "244e8f58-8aba-5ede-0b9d-a566f1021cfb", "openfda": {"nui": ["N0000175582", "N0000000145", "N0000000168"], "unii": ["22X328QOC4"], "rxcui": ["727762"], "spl_set_id": ["67566681-19b5-89df-2030-25df5b0cf641"], "pharm_class_epc": ["Estrogen Receptor Antagonist [EPC]"], "pharm_class_moa": ["Estrogen Receptor Antagonists [MoA]", "Selective Estrogen Receptor Modulators [MoA]"], "manufacturer_name": ["Northstar Rx, LLC,"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE, GLASS in 1 CARTON (16714-070-02)  / 5 mL in 1 SYRINGE, GLASS (16714-070-01)", "package_ndc": "16714-070-02", "marketing_start_date": "20210823"}], "brand_name": "FULVESTRANT", "product_id": "16714-070_244e8f58-8aba-5ede-0b9d-a566f1021cfb", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Estrogen Receptor Antagonist [EPC]", "Estrogen Receptor Antagonists [MoA]", "Selective Estrogen Receptor Modulators [MoA]"], "product_ndc": "16714-070", "generic_name": "fulvestrant", "labeler_name": "Northstar Rx, LLC,", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "FULVESTRANT", "active_ingredients": [{"name": "FULVESTRANT", "strength": "50 mg/mL"}], "application_number": "ANDA213553", "marketing_category": "ANDA", "marketing_start_date": "20210823", "listing_expiration_date": "20261231"}